QualityDipStocks / Finance · Property-Casualty Insurers
Lemonade LMND
Outside our quality screen, so we don’t track its dips. It’s 57% below its 52-week high.
Outside our quality screen, 15% under its Market Value. No fair value estimate for now: our model doesn’t fit it reliably.
Worth knowing
- Down 59% from its 52-week high while revenue grew 62%
- Deepest drop from a 52-week high in over 3 years
From the data on this page, as of the last close. How we pick these
- Fair value est.
- n/a
- Market Value
- $48.37price −15%
- Off 52-wk high
- −57%
- Risk vs market
- Highbeta 2.57
3 bullish · 5 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
Estimate unreliable for LMND: earnings swing too much for a book-value model (return on equity ranged from -32% to -27% across FY2021–2025 and the latest 12 months). We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much LMND moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings much more than the market, and its own price swings are 6.1× the S&P 500’s.
- Beta vs S&P 500
- 2.57
- Volatility
- 78% vs 13% SPY
- Correlation SPY
- 0.42
- Correlation QQQ
- 0.36
Valuation details
MV $48.37
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 3 of 5
GrowthSales grew 62% to $975M over the last 12 months vs the 12 months before (SEC filings).
GrowthSales compounded 42% a year from FY2022 to FY2025.
ValuationTrades 14.8% below its Market Value of $48.37, the average price paid since the Jul 29 filing.
Top bearish points 5 of 5
Cash returnsShare count up 4.8% in a year: existing holders are being diluted.
ProfitabilityReturn on equity of −27%, below the 12% median for the 291 Finance companies we cover.
ValuationPrice / book of 6.4×, above the 1.7× median for the 296 Finance companies we cover.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%.
RiskSwings hard: beta 2.57 vs the S&P 500 and 78% yearly volatility (SPY 13%).
All fundamentals
ROE -27% · Sales +62%
Valuation
- P/E
- n/aloss over the last 12 months
- Price / FCF
- n/acash flow isn't a clean measure for an insurer
- FCF yield
- n/acash flow isn't a clean measure for an insurer
- EV / EBITDA
- n/anot meaningful for an insurer
- Price / sales
- 3.28×
- Price / book
- 6.41×
- Market cap
- $3.2Blisted
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $975M
- Sales growth, 12 months
- +62.3%vs the 12 months before
- Sales growth, 3 yrs
- +42.2%/yrfrom FY2022
- Diluted EPS, 12 months
- −$1.82
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- −$138M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- n/anot meaningful for an insurer
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- −14.2%
- FCF margin
- 0.8%
- Return on equity
- −27%
- Return on invested capital
- n/anot meaningful for an insurer
Balance sheet
- Cash & short-term inv.
- $377M
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/anot meaningful for an insurer
- Debt / equity
- n/adeposits/float make debt/equity not comparable for an insurer
- Interest coverage
- n/anot meaningful for an insurer
Cash flow & returns
- Free cash flow, 12 months
- $8M
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +4.8%diluted shares vs a year ago
- Stock-based comp
- $81M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From Lemonade’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.0B · Sales +79%
- Free cash flow, 12 months$0.0B
- Free-cash-flow yield0.3%
- Return on equity−27%
- Sales growth (latest quarter vs year-ago quarter)+79%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $41.19
- 52-wk lowlowest close, 1 year$41.19at the price
- PriceMon Nov 2 close$41.19you are here
- Market Valueavg paid since Jul 29$48.37+17.4%
- 52-wk highhighest close, 1 year$96.57+134.5%
Momentum & 52-week range
RSI 33 · 5 days −8.6%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 5
- DateThu Nov 5, before the open
- Consensus EPS($0.60)
- Year-ago EPS($0.51)
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
LMND is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Lemonade in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Property-Casualty Insurers
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.